The pharmaceutical supply chain is under pressure to shift from just-in-time models to resilient, visibility-driven systems after COVID exposed vulnerabilities in cold chain logistics. A survey of 100 executives showed product protection, supplier visibility, and timing as top concerns, with up to 20% vaccine waste linked to poor monitoring. Nearly all organizations plan to adopt advanced visibility solutions within a year, leveraging IoT and real-time security reporting to mitigate theft, temperature excursions, and compliance failures. Quality assurance, predictive ETAs, and end-to-end transparency are now critical for reducing losses, cutting costs, and ensuring timely, safe delivery to patients.

Join for free to read